X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3865) 3865
Publication (250) 250
Book Review (43) 43
Book Chapter (32) 32
Dissertation (8) 8
Web Resource (7) 7
Conference Proceeding (6) 6
Book / eBook (4) 4
Magazine Article (3) 3
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2695) 2695
febrile neutropenia (2612) 2612
index medicus (1977) 1977
female (1690) 1690
male (1513) 1513
oncology (1498) 1498
middle aged (1231) 1231
cancer (1200) 1200
neutropenia (1172) 1172
chemotherapy (1160) 1160
adult (1099) 1099
aged (1052) 1052
fever (744) 744
hematology (708) 708
adolescent (627) 627
risk factors (574) 574
child (562) 562
retrospective studies (556) 556
colony-stimulating factor (523) 523
treatment outcome (517) 517
antineoplastic agents - adverse effects (482) 482
infectious diseases (478) 478
neoplasms - drug therapy (455) 455
mortality (454) 454
pharmacology & pharmacy (454) 454
anti-bacterial agents - therapeutic use (448) 448
children (439) 439
neutropenia - chemically induced (436) 436
medicine & public health (433) 433
antineoplastic combined chemotherapy protocols - adverse effects (429) 429
cancer-patients (418) 418
pediatrics (418) 418
child, preschool (402) 402
prospective studies (402) 402
care and treatment (401) 401
neoplasms - complications (397) 397
aged, 80 and over (382) 382
neutropenia - drug therapy (376) 376
infection (369) 369
bacteremia (361) 361
therapy (357) 357
management (356) 356
antineoplastic combined chemotherapy protocols - therapeutic use (343) 343
infections (343) 343
young adult (334) 334
granulocyte colony-stimulating factor - therapeutic use (329) 329
antibiotics (315) 315
neutropenia - complications (309) 309
health aspects (305) 305
analysis (300) 300
filgrastim (300) 300
granulocyte colony-stimulating factor (281) 281
infant (280) 280
health care sciences & services (268) 268
research (264) 264
leukemia (256) 256
fever - etiology (253) 253
breast cancer (252) 252
risk (248) 248
double-blind (247) 247
microbiology (245) 245
medicine, general & internal (243) 243
prognosis (243) 243
breast-cancer (239) 239
patients (236) 236
neutropenia - etiology (232) 232
antineoplastic agents - therapeutic use (231) 231
g-csf (229) 229
fever - drug therapy (226) 226
pegfilgrastim (225) 225
breast neoplasms - drug therapy (223) 223
cancer patients (223) 223
nursing (221) 221
prophylaxis (217) 217
rehabilitation (216) 216
guidelines (213) 213
sepsis (211) 211
drug therapy (206) 206
anti-bacterial agents - administration & dosage (197) 197
diagnosis (196) 196
c-reactive protein (190) 190
epidemiology (189) 189
immunology (187) 187
incidence (184) 184
neutropenia - prevention & control (182) 182
febrile neutropenia - chemically induced (179) 179
febrile neutropenia - drug therapy (178) 178
induced febrile neutropenia (170) 170
internal medicine (166) 166
non-hodgkins-lymphoma (162) 162
pain medicine (162) 162
medical research (161) 161
hematology, oncology and palliative medicine (159) 159
drug administration schedule (158) 158
rehabilitation medicine (158) 158
transplantation (156) 156
antineoplastic combined chemotherapy protocols - administration & dosage (155) 155
hematologic neoplasms - complications (155) 155
multicenter (154) 154
chemotherapy-induced neutropenia (151) 151
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3547) 3547
Spanish (114) 114
French (77) 77
German (50) 50
Japanese (46) 46
Turkish (33) 33
Czech (15) 15
Russian (14) 14
Polish (7) 7
Hungarian (6) 6
Chinese (5) 5
Portuguese (5) 5
Italian (4) 4
Korean (3) 3
Lithuanian (2) 2
Slovak (2) 2
Croatian (1) 1
Danish (1) 1
Indonesian (1) 1
Persian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Haematology, ISSN 0902-4441, 02/2019, Volume 102, Issue 2, pp. 174 - 181
Objective The prospective non‐interventional study (NIS) NADIR was designed to evaluate both effectiveness and safety of prophylactic use of lipegfilgrastim... 
granulocyte colony‐stimulating factor | non‐Hodgkin lymphoma | routine clinical practice | primary prophylaxis | chemotherapy‐induced febrile neutropenia | lipegfilgrastim | non-Hodgkin lymphoma | granulocyte colony-stimulating factor | chemotherapy-induced febrile neutropenia | MANAGEMENT | COLONY-STIMULATING FACTOR | GUIDELINES | RISK | CANCER | CNOP | RECEIVING CHOP | HEMATOLOGY | Prospective Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Chemotherapy-Induced Febrile Neutropenia - prevention & control | Male | Febrile Neutropenia - prevention & control | Polyethylene Glycols - therapeutic use | Incidence | Young Adult | Lymphoma, Non-Hodgkin - complications | Aged, 80 and over | Adult | Female | Filgrastim - therapeutic use | Chemotherapy-Induced Febrile Neutropenia - diagnosis | Lymphoma, Non-Hodgkin - drug therapy | Febrile Neutropenia - diagnosis | Comorbidity | Treatment Outcome | Filgrastim - administration & dosage | Polyethylene Glycols - administration & dosage | Febrile Neutropenia - etiology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Lymphoma, Non-Hodgkin - diagnosis | Prophylaxis | Clinical trials | Myalgia | Lymphoma | Chemotherapy | Leukocytosis | Pain | Motivation | Lymphomas | Clinical medicine | Leukocytes (granulocytic) | Neutropenia | Cancer
Journal Article
Journal Article
Journal Article
Journal of Clinical Gastroenterology, ISSN 0192-0790, 10/2019, Volume 53, Issue 9, pp. e376 - e381
INTRODUCTION:Clostridium difficile infection (CDI) has been attracting attention lately as the most common hospital acquired infection. Patients with... 
clostridium difficile colitis | National inpatient sample | febrile neutropenia | PATHOGENESIS | DIAGNOSIS | RISK-FACTORS | DIARRHEA | DISEASE | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | BURDEN | EPIDEMIOLOGY
Journal Article
Journal Article